Terumo Corp. revenue for the last year amounted to 6.01 B USD, the most of which — 3.55 B USD — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 3.53 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Terumo Corp. 1.82 B USD, and the year before that — 1.70 B USD.